Top

Published in:

01-10-2019 | Gene Therapy in Oncology | Editorial

Non-muscle invasive bladder cancer (NMIBC): boiling arena and promissory future

Author: Leonardo O. Reis

Published in: World Journal of Urology | Issue 10/2019

Excerpt

Non-muscle invasive bladder cancer (NMIBC) is a rapidly developing and intriguing field with many challenging faces while cystoscopy, transurethral resection, and intravesical bacillus Calmette–Guérin (BCG) have withstood the test of time remaining the gold standards; there has been an explosion of research in this scenario. …

García-Perdomo HA, Usubillaga-Velasquez JP, Zapata-Copete JA, Reis LO (2019) Mutations in CDKN2A and the FGFR3 genes on bladder cancer diagnosis: a systematic review and meta-analysis. World J Urol. https://doi.org/10.1007/s00345-019-02779-7 CrossRefPubMed

Faiena I, Rosser CJ, Chamie K, Furuya H (2018) Diagnostic biomarkers in non-muscle invasive bladder cancer. World J Urol. https://doi.org/10.1007/s00345-018-2567-1 CrossRefPubMed

Peyton CC, Chipollini J, Azizi M, Kamat AM, Gilbert SM, Spiess PE (2018) Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what. World J Urol. https://doi.org/10.1007/s00345-018-2591-1 CrossRefPubMed

Werntz RP, Adamic B, Steinberg GD (2018) Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC). World J Urol. https://doi.org/10.1007/s00345-018-2592-0 CrossRefPubMed

Duplisea JJ, Mokkapati S, Plote D, Schluns KS, McConkey DJ, Yla-Herttuala S, Parker NR, Dinney CP (2018) The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside. World J Urol. https://doi.org/10.1007/s00345-018-2553-7 CrossRefPubMed

Gupta M, Milbar N, Tema G, Pederzoli F, Chappidi M, Kates M, Vanden Bussche CJ, Bivalacqua TJ (2019) Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology. World J Urol. https://doi.org/10.1007/s00345-018-02624-3 CrossRefPubMed

Mossanen M, Wang Y, Szymaniak J, Tan WS, Huynh MJ, Preston MA, Trinh QD, Sonpavde G, Kibel AS, Chang SL (2018) Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories. World J Urol. https://doi.org/10.1007/s00345-018-2550-x CrossRefPubMed

Datovo JCF, Neto WA, Mendonça GB, Andrade DL, Reis LO (2019) Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC). World J Urol. https://doi.org/10.1007/s00345-019-02697-8 CrossRefPubMed

Carneiro BDB, Sanches BCF, Andrade DL, Voris BRI, Reis LO (2019) Moreau strain bacillus Calmette-Guérin low versus standard dose in the treatment of high-grade T1 bladder cancer: a retrospective observational cohort study. Clin Genitourin Cancer. 17(4):e779–e783. https://doi.org/10.1016/j.clgc.2019.04.003 CrossRefPubMed

Title: Non-muscle invasive bladder cancer (NMIBC): boiling arena and promissory future
Author: Leonardo O. Reis
Publication date: 01-10-2019
Publisher: Springer Berlin Heidelberg
Keyword: Gene Therapy in Oncology
Published in: World Journal of Urology / Issue 10/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-019-02894-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Non-muscle invasive bladder cancer (NMIBC): boiling arena and promissory future

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2019

Clinically occult prostate cancer cases may distort the effect of testosterone replacement therapy on risk of PCa

Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis

The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside

Confocal laser endomicroscopy for upper tract urothelial carcinoma: validation of the proposed criteria and proposal of a scoring system for real-time tumor grading

Incorporating non-biological factors into the TNM staging system for better prognostication and decision-making in testicular cancer

Liquid chromatography–mass spectrometry identification of serum biomarkers for nocturia in aged men